NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-300-2009-5-DE-14 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use DE EP 10760878.8 Issued
NIAID E-300-2009-5-CH-13 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use CH EP 10760878.8 Issued
NIAID E-300-2009-5-GB-16 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use GB EP 10760878.8 Issued
NIAID E-300-2009-5-EP-05 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use EP National Stage 10760878.8 Issued
NIAID E-300-2009-5-ZA-08 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use ZA National Stage 2012/02116 Issued
NCI E-018-2005-2-CA-03 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS CA National Stage 2596845 Expired
NIAID E-300-2009-5-AU-02 Neutralizing Antibodies To HIV-1 And Their Use AU National Stage 2010298025 Issued
NIAID E-300-2009-5-CN-04 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use CN National Stage 201080053616.5 Issued
NIAID E-319-2004-2-CA-04 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses CA National Stage 2581840 Expired
NIAID E-300-2009-5-PCT-01 Neutralizing Monoclonal Antibodies To HIV-1 And Their Use PCT PCT COMB PCT/US2010/050295 Expired
NIAID E-146-2008-2-US-03 Induction Of Profliferation, Effector Molecule Expression, And Cytolytic Capacity Of HIV -Specific CDS + T Cells US National Stage 12/934,522 Abandoned
NIAID E-292-2010-0-US-01 Novel HIV-1 Broadly Neutralizing Antibodies US 61/386,211 Abandoned
NCI E-090-2000-1-GB-15 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 GB EP 10010354.8 Expired
NCI E-200-1998-0-ES-45 FITNESS ASSAY AND ASSOCIATED METHODS ES EP 10179052.5 Expired
NCI E-200-1998-0-GB-48 FITNESS ASSAY AND ASSOCIATED METHODS GB EP 10179052.5 Expired
NCI E-200-1998-0-SE-57 FITNESS ASSAY AND ASSOCIATED METHODS SE EP 10179052.5 Expired
NCI E-200-1998-0-CH-41 FITNESS ASSAY AND ASSOCIATED METHODS CH EP 10179052.5 Expired
NCI E-200-1998-0-MC-54 FITNESS ASSAY AND ASSOCIATED METHODS MC EP 10179052.5 Expired
NCI E-200-1998-0-PT-56 FITNESS ASSAY AND ASSOCIATED METHODS PT EP 10179052.5 Expired
NCI E-200-1998-0-NL-55 FITNESS ASSAY AND ASSOCIATED METHODS NL EP 10179052.5 Expired
NCI E-200-1998-0-LI-52 FITNESS ASSAY AND ASSOCIATED METHODS LI EP 10179052.5 Expired
NCI E-200-1998-0-LU-53 FITNESS ASSAY AND ASSOCIATED METHODS LU EP 10179052.5 Expired
NCI E-200-1998-0-GR-49 FITNESS ASSAY AND ASSOCIATED METHODS GR EP 10179052.5 Expired
NCI E-200-1998-0-IT-51 FITNESS ASSAY AND ASSOCIATED METHODS IT EP 10179052.5 Expired
NCI E-200-1998-0-IE-50 FITNESS ASSAY AND ASSOCIATED METHODS IE EP 10179052.5 Expired
NCI E-200-1998-0-CY-42 FITNESS ASSAY AND ASSOCIATED METHODS CY EP 10179052.5 Expired
NCI E-200-1998-0-DE-43 FITNESS ASSAY AND ASSOCIATED METHODS DE EP 10179052.5 Expired
NCI E-200-1998-0-FI-46 FITNESS ASSAY AND ASSOCIATED METHODS FI EP 10179052.5 Expired
NCI E-200-1998-0-FR-47 FITNESS ASSAY AND ASSOCIATED METHODS FR EP 10179052.5 Expired
NCI E-200-1998-0-DK-44 FITNESS ASSAY AND ASSOCIATED METHODS DK EP 10179052.5 Expired
NCI E-200-1998-0-BE-40 FITNESS ASSAY AND ASSOCIATED METHODS BE EP 10179052.5 Expired
NCI E-200-1998-0-AT-39 FITNESS ASSAY AND ASSOCIATED METHODS AT EP 10179052.5 Expired
NCI E-080-2008-0-US-03 Human Monoclonal Antibodies Sepcific for CD22 US National Stage 12/934,214 8591889 Issued PDF
NCI E-217-2005-2-US-07 HUMAN MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND IGF-II US DIV 12/889,345 8105598 Abandoned PDF
NCI E-204-2009-2-PCT-01 Composition and Methods for Silencing Genes Expressed in Cancer PCT PCT COMB PCT/US2010/050077 Expired
NCI E-204-2009-2-EP-03 Composition and Methods for Silencing Genes Expressed in Cancer EP National Stage 10777133.9 Abandoned
NHGRI E-244-2010-0-US-01 GRM3 Mutations And Use Thereof For The Diagnosis And Treatment of Melanoma US 61/385,925 Abandoned
NCI E-204-2009-2-CA-02 Composition and Methods for Silencing Genes Expressed in Cancer CA National Stage 2775092 Abandoned
NIMH E-156-2006-0-US-04 Beta-amyloid PET Imaging Agents US National Stage 12/293,340 8703096 Abandoned PDF
NCI E-079-2008-0-US-06 Human Anti-Mesothelin Monoclonal Antibodies US National Stage 12/934,060 8357783 Issued PDF
NCATS E-188-2009-2-PCT-01 AMINOTHIENOPYRIDAZINE INHIBITORS OF TAU ASSEMBLY PCT PCT COMB PCT/US2010/049799 Expired
NIDDK E-068-2010-1-US-01 Genotype 1b Hepatitis C Virus Cell Culture System. US 61/385,477 Abandoned
NIBIB E-105-2010-0-US-01 Scanningless Multiphoton Microscopy With Diffraction-limited Axial Resolution US 61/385,409 Abandoned
NIAID E-300-2009-6-US-01 Neutralizing Antibodies To HIV-1 And Their Use US 61/385,531 Abandoned
NIAID E-053-2008-1-US-02 Aerosolized Genetic Vaccines And Methods of Use US National Stage 12/887,286 Abandoned
NCI E-269-2010-0-US-01 Anti SSX2 T Cell Receptors And Related Materials and Methods of Use US 61/384,931 Abandoned
NIAID E-229-2003-2-JP-24 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof JP DIV 2010-209408 Abandoned
NIAID E-043-2010-0-EP-03 INFECTIOUS HEPATITIS C VIRUSES OF GENOTYPE 3A AND 4A AND USES THEREOF EP National Stage 10754407.4 Abandoned
NIAID E-043-2010-0-US-04 Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof US National Stage 13/499,663 8946398 Abandoned PDF
NCI E-171-2010-1-PCT-01 HIV-l ANTIBODIES PCT PCT COMB PCT/US2010/002515 Expired